Ketorolac Doc Generici

Ketorolac Trometamol, the active ingredient in Ketorolac Doc Generici, is a nonsteroidal anti‑inflammatory drug presented as a sterile injectable solution for intramuscular or intravenous use. It is employed to manage moderate to severe pain, particularly after surgery, in adult patients.

GNH USA supplies Ketorolac Doc Generici as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company provides regulatory‑approved batches, ensuring quality and traceability for global healthcare providers, including hospitals, clinics and procurement agencies across Europe, Asia and the Americas.

Ketorolac Trometamol is an NSAID that reduces pain and inflammation by inhibiting cyclooxygenase enzymes. - Post‑operative pain: provides effective analgesia after surgical procedures. - Acute musculoskeletal pain: relieves moderate to severe pain from injuries or strains. - Renal colic: offers short‑term pain control in kidney‑stone episodes.

Ketorolac Trometamol may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo: transient sensations of light‑headedness. - Injection site reactions: erythema, swelling or pain at the site.

Serious or Rare Side Effects: - Bleeding: gastrointestinal ulceration or hemorrhage. - Renal impairment: acute kidney injury, especially with prolonged use. - Cardiovascular events: hypertension, myocardial infarction or stroke. - Severe hypersensitivity: anaphylaxis, angioedema or skin rash.

When prescribing Ketorolac Trometamol, clinicians should observe several safety considerations to minimize risk. - Duration of therapy: limit use to the shortest possible period, generally not exceeding five days. - Renal function: avoid or adjust in patients with impaired kidney function. - Bleeding risk: use cautiously in individuals with a history of ulcers or anticoagulant therapy. - Cardiovascular status: monitor blood pressure and avoid in uncontrolled hypertension. - Pregnancy and lactation: contraindicated in the third trimester and use only if benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ketorolac Trometamol can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, heparin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs) or SNRIs: amplified bleeding tendency.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, monitor kidney function. - Diuretics: potential for reduced effectiveness and renal effects. - Lithium: NSAIDs can increase lithium levels, monitor serum concentration.